Therapeutics to tackle Omicron outbreak-Reference-Cited by-同舟云学术

Therapeutics to tackle Omicron outbreak

Published:2022-08 Issue:11 Volume:14 Page:833-838
ISSN:1750-743X
Container-title:Immunotherapy
language:en
Short-container-title:Immunotherapy

Author:

Chavda Vivek P¹^ORCID,Hanuma Kumar Ghali Eswara Naga²³,Yallapu Murali M²³,Apostolopoulos Vasso⁴⁵^ORCID

Affiliation:

1. Department of Pharmaceutics & Pharmaceutical Technology, LM College of Pharmacy, Ahmedabad, Gujarat, 380008, India

2. Department of Immunology & Microbiology, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX 78504, USA

3. South Texas Center of Excellence in Cancer Research, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX 78504, USA

4. Institute for Health & Sport, Victoria University, Melbourne, Victoria, 3030, Australia

5. Immunology Program, Australian Institute for Musculoskeletal Science (AIMSS), Melbourne, Victoria, 3021, Australia

Abstract

Tweetable abstract In this commentary, the authors have focused on the mutational impact of the Omicron variant on the current therapeutics to manage #COVID19.

Publisher

Future Medicine Ltd

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.futuremedicine.com/doi/pdf/10.2217/imt-2022-0064

Reference46 articles.

1. A global picture: therapeutic perspectives for COVID-19

2. New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications

3. Global impact of delta plus variant and vaccination

4. SARS‐CoV‐2 variants and vulnerability at the global level

5. Omicron variant (B.1.1.529) of SARS-CoV-2: Threat for the elderly?

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protein subunit vaccines: Promising frontiers against COVID-19;Journal of Controlled Release;2024-02

2. The role of electric charge in SARS-CoV-2 and other viral infections;AIMS Biophysics;2024

3. New approaches to vaccines for autoimmunity;Advanced Vaccination Technologies for Infectious and Chronic Diseases;2024

4. Vaccine adjuvants and carriers;Advanced Vaccination Technologies for Infectious and Chronic Diseases;2024

5. Preclinical and clinical development for vaccines and formulations;Advanced Vaccination Technologies for Infectious and Chronic Diseases;2024